S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|ImmunoGen's stock plunges after Roche's disappointing trial results prompts downgrade|
|ImmunoGen, Inc. Announces 2015 Outlook for Product Pipeline|
|ImmunoGen, Inc. Announces Conference Call to Discuss its Second Quarter Fiscal Year 2015 Financial Results|
|ImmunoGen Reports Roche Has Provided an Update on the MARIANNE Trial|
|ImmunoGen, Inc. Announces Clinical and Preclinical Data Presentations at Upcoming 56th ASH Annual Meeting and Exposition|
|ImmunoGen, Inc. Announces Webcast of Presentation at the 33rd Annual J.P. Morgan Healthcare Conference|
|ImmunoGen, Inc. Reports First Quarter Fiscal Year 2015 Financial Results|
|ImmunoGen, Inc. Appoints Richard J. Gregory, Ph.D. as EVP, Chief Scientific Officer; John M. Lambert, Ph.D. Named EVP, Distinguished Research Fellow|
|ImmunoGen, Inc. Again Named One of The Boston Globe’s Top Places to Work|
|ImmunoGen, Inc. Announces Encouraging IMGN529 Clinical Data Presented at 56th ASH Annual Meeting and Exposition|
Click above to view more mutual fund data and stats for imgn - Immunogen Inc.